{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:01:52Z","timestamp":1780509712142,"version":"3.54.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05880-2","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:26:26Z","timestamp":1777803986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["miRNAs in Amyotrophic Lateral Sclerosis: Tiny Molecules, Tremendous Impact"],"prefix":"10.1007","volume":"63","author":[{"given":"Sherif S.","family":"Abdel Mageed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Abdulkader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah Ahmed Mohamed","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"5880_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells12111523","author":"L Tzeplaeff","year":"2023","unstructured":"Tzeplaeff L, Wilfling S, Requardt MV, Herdick M (2023) Current state and future directions in the therapy of ALS. Cells. https:\/\/doi.org\/10.3390\/cells12111523","journal-title":"Cells"},{"key":"5880_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/life15040647","author":"M Gonz\u00e1lez-S\u00e1nchez","year":"2025","unstructured":"Gonz\u00e1lez-S\u00e1nchez M, Ram\u00edrez-Exp\u00f3sito MJ, Mart\u00ednez-Martos JM (2025) Pathophysiology, clinical heterogeneity, and therapeutic advances in amyotrophic lateral sclerosis: a comprehensive review of molecular mechanisms, diagnostic challenges, and multidisciplinary management strategies. Life. https:\/\/doi.org\/10.3390\/life15040647","journal-title":"Life"},{"issue":"3\u20134","key":"5880_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, Mioshi E, Roberts-South A, et al. (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18(3\u20134):153\u2013174","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"10107","key":"5880_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH (2017) Amyotrophic lateral sclerosis. Lancet 390(10107):2084\u20132098","journal-title":"Lancet"},{"issue":"1","key":"5880_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia R, Chi\u00f2 A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17(1):94\u2013102","journal-title":"Lancet Neurol"},{"key":"5880_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115240","author":"C Tolochko","year":"2025","unstructured":"Tolochko C, Shiryaeva O, Alekseeva T, Dyachuk V (2025) Amyotrophic lateral sclerosis: pathophysiological mechanisms and treatment strategies (part 2). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26115240","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5880_CR7","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, et al. (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3(1):17071","journal-title":"Nat Rev Dis Primers"},{"issue":"7628","key":"5880_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539(7628):197\u2013206","journal-title":"Nature"},{"issue":"5","key":"5880_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32(5):771\u2013776","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"5880_CR10","doi-asserted-by":"publisher","first-page":"13805","DOI":"10.1038\/s41598-023-40879-y","volume":"13","author":"J Cheng","year":"2023","unstructured":"Cheng J, Ho WK, Wu BT, Liu HP, Lin WY (2023) miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis. Sci Rep 13(1):13805","journal-title":"Sci Rep"},{"issue":"5","key":"5880_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae268","volume":"6","author":"SA Banack","year":"2024","unstructured":"Banack SA, Dunlop RA, Mehta P, Mitsumoto H, Wood SP, Han M, Cox PA (2024) A microRNA diagnostic biomarker for amyotrophic lateral sclerosis. Brain Commun 6(5):fcae268","journal-title":"Brain Commun"},{"issue":"5","key":"5880_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/WCO.0000000000000594","volume":"31","author":"CV Ly","year":"2018","unstructured":"Ly CV, Miller TM (2018) Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis. Curr Opin Neurol 31(5):648\u2013654","journal-title":"Curr Opin Neurol"},{"key":"5880_CR13","doi-asserted-by":"publisher","first-page":"1131758","DOI":"10.3389\/fnins.2023.1131758","volume":"17","author":"Y Koike","year":"2023","unstructured":"Koike Y, Onodera O (2023) Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications. Front Neurosci 17:1131758","journal-title":"Front Neurosci"},{"key":"5880_CR14","doi-asserted-by":"publisher","first-page":"1401706","DOI":"10.3389\/fnins.2024.1401706","volume":"18","author":"D Bradford","year":"2024","unstructured":"Bradford D, Rodgers KE (2024) Advancements and challenges in amyotrophic lateral sclerosis. Front Neurosci 18:1401706","journal-title":"Front Neurosci"},{"issue":"1","key":"5880_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP (2018) Metazoan MicroRNAs. Cell 173(1):20\u201351","journal-title":"Cell"},{"issue":"8","key":"5880_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11011-025-01730-7","volume":"40","author":"RM Mansour","year":"2025","unstructured":"Mansour RM, Rizk NI, Abdel Mageed SS, Alam-Eldein KM, Fahmy HA, Lutfy RH, Shafey MM, Mohamed HH, et al. (2025) miRNA dysregulation in depression: unraveling the interplay between neuroplasticity, HPA axis dysfunction, and neuroinflammation. Metab Brain Dis 40(8):308","journal-title":"Metab Brain Dis"},{"issue":"7","key":"5880_CR17","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1007\/s12035-025-04750-7","volume":"62","author":"RM Mansour","year":"2025","unstructured":"Mansour RM, Shaker AAS, Abulsoud AI, Mageed SSA, Ashraf A, Elsakka EGE, Dahab MI, Sadek MM, et al. (2025) The Role of MicroRNAs in Neurodegeneration: Insights from Huntington\u2019s Disease. Mol Neurobiol 62(7):8502\u20138517","journal-title":"Mol Neurobiol"},{"key":"5880_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.brainresbull.2023.01.005","volume":"194","author":"H Liu","year":"2023","unstructured":"Liu H, Lan S, Shi XJ, Fan FC, Liu QS, Cong L, Cheng Y (2023) Systematic review and meta-analysis on microRNAs in amyotrophic lateral sclerosis. Brain Res Bull 194:82\u201389","journal-title":"Brain Res Bull"},{"issue":"5959","key":"5880_CR19","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, et al. (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York, NY) 326(5959):1549\u20131554","journal-title":"Science (New York, NY)"},{"issue":"9","key":"5880_CR20","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1172\/JCI62636","volume":"122","author":"O Butovsky","year":"2012","unstructured":"Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, et al. (2012) Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest 122(9):3063\u20133087","journal-title":"J Clin Invest"},{"issue":"2","key":"5880_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mus.26106","volume":"58","author":"R Raheja","year":"2018","unstructured":"Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, et al. (2018) Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve 58(2):261\u2013269","journal-title":"Muscle Nerve"},{"issue":"1","key":"5880_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1261\/rna.068692.118","volume":"25","author":"G Michlewski","year":"2019","unstructured":"Michlewski G, C\u00e1ceres JF (2019) Post-transcriptional control of miRNA biogenesis. RNA (New York, NY) 25(1):1\u201316","journal-title":"RNA (New York, NY)"},{"issue":"1","key":"5880_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70119","volume":"39","author":"AS Doghish","year":"2025","unstructured":"Doghish AS, Abulsoud AI, Nassar YA, Nasr SM, Mohammed OA, Abdel-Reheim MA, Rizk NI, Lutfy RH, et al. (2025) Harnessing miRNAs: a novel approach to diagnosis and treatment of tuberculosis. J Biochem Mol Toxicol 39(1):e70119","journal-title":"J Biochem Mol Toxicol"},{"issue":"4","key":"5880_CR24","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.cell.2019.06.023","volume":"178","author":"JJ Cassidy","year":"2019","unstructured":"Cassidy JJ, Bernasek SM, Bakker R, Giri R, Pel\u00e1ez N, Eder B, Bobrowska A, Bagheri N, et al. (2019) Repressive gene regulation synchronizes development with cellular metabolism. Cell 178(4):980-992.e17","journal-title":"Cell"},{"issue":"5","key":"5880_CR25","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH (2019) An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol 234(5):5451\u20135465","journal-title":"J Cell Physiol"},{"issue":"30","key":"5880_CR26","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1073\/pnas.1008227107","volume":"107","author":"SC Ling","year":"2010","unstructured":"Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, Cleveland DW (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS\/TLS. Proc Natl Acad Sci USA 107(30):13318\u201313323","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"5880_CR27","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1038\/emboj.2012.319","volume":"31","author":"M Morlando","year":"2012","unstructured":"Morlando M, Dini Modigliani S, Torrelli G, Rosa A, Di Carlo V, Caffarelli E, Bozzoni I (2012) Fus stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J 31(24):4502\u20134510","journal-title":"EMBO J"},{"key":"5880_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fncel.2020.00117","volume":"14","author":"X Paez-Colasante","year":"2020","unstructured":"Paez-Colasante X, Figueroa-Romero C, Rumora AE, Hur J, Mendelson FE, Hayes JM, Backus C, Taubman GF, et al. (2020) Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis. Front Cell Neurosci 14:117","journal-title":"Front Cell Neurosci"},{"issue":"R2","key":"5880_CR29","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1093\/hmg\/ddp303","volume":"18","author":"GS Pesiridis","year":"2009","unstructured":"Pesiridis GS, Lee VM, Trojanowski JQ (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet 18(R2):R156\u2013R162","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5880_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2051-5960-1-42","volume":"1","author":"A Freischmidt","year":"2013","unstructured":"Freischmidt A, M\u00fcller K, Ludolph AC, Weishaupt JH (2013) Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun 1(1):42","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"5880_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79(3):416\u2013438","journal-title":"Neuron"},{"issue":"9","key":"5880_CR32","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1073\/pnas.1112427109","volume":"109","author":"Y Kawahara","year":"2012","unstructured":"Kawahara Y, Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci USA 109(9):3347\u20133352","journal-title":"Proc Natl Acad Sci USA"},{"key":"5880_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051534","author":"L Di Pietro","year":"2018","unstructured":"Di Pietro L, Lattanzi W, Bernardini C (2018) Skeletal muscle MicroRNAs as key players in the pathogenesis of amyotrophic lateral sclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19051534","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5880_CR34","doi-asserted-by":"publisher","first-page":"e89065","DOI":"10.1371\/journal.pone.0089065","volume":"9","author":"JM Toivonen","year":"2014","unstructured":"Toivonen JM, Manzano R, Oliv\u00e1n S, Zaragoza P, Garc\u00eda-Redondo A, Osta R (2014) MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE 9(2):e89065","journal-title":"PLoS ONE"},{"issue":"3","key":"5880_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5414\/NP301233","volume":"39","author":"V Pegoraro","year":"2020","unstructured":"Pegoraro V, Marozzo R, Angelini C (2020) MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients. Clin Neuropathol 39(3):105\u2013114","journal-title":"Clin Neuropathol"},{"key":"5880_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2012.08.015","volume":"49","author":"AP Russell","year":"2013","unstructured":"Russell AP, Wada S, Vergani L, Hock MB, Lamon S, L\u00e9ger B, Ushida T, Cartoni R, et al. (2013) Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 49:107\u2013117","journal-title":"Neurobiol Dis"},{"issue":"3","key":"5880_CR37","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s12035-017-0537-z","volume":"55","author":"P Rinchetti","year":"2018","unstructured":"Rinchetti P, Rizzuti M, Faravelli I, Corti S (2018) MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis. Mol Neurobiol 55(3):2617\u20132630","journal-title":"Mol Neurobiol"},{"issue":"20","key":"5880_CR38","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","volume":"22","author":"ED Koval","year":"2013","unstructured":"Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF, et al. (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22(20):4127\u20134135","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5880_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/cdd.2015.153","volume":"23","author":"C Parisi","year":"2016","unstructured":"Parisi C, Napoli G, Amadio S, Spalloni A, Apolloni S, Longone P, Volont\u00e9 C (2016) Microrna-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ 23(3):531\u2013541","journal-title":"Cell Death Differ"},{"key":"5880_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnmol.2017.00160","volume":"10","author":"C Li","year":"2017","unstructured":"Li C, Chen Y, Chen X, Wei Q, Cao B, Shang H (2017) Downregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1\/mTOR Signaling in NSC-34 Cells. Front Mol Neurosci 10:160","journal-title":"Front Mol Neurosci"},{"issue":"15","key":"5880_CR41","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1111\/jcmm.15490","volume":"24","author":"C Li","year":"2020","unstructured":"Li C, Chen Y, Chen X, Wei Q, Ou R, Gu X, Cao B, Shang H (2020) Microrna-183-5p is stress-inducible and protects neurons against cell death in amyotrophic lateral sclerosis. J Cell Mol Med 24(15):8614\u20138622","journal-title":"J Cell Mol Med"},{"key":"5880_CR42","doi-asserted-by":"publisher","first-page":"676575","DOI":"10.1155\/2015\/676575","volume":"2015","author":"M Nie","year":"2015","unstructured":"Nie M, Deng ZL, Liu J, Wang DZ (2015) Noncoding RNAs Emerging Regulators of Skeletal Muscle Development and Diseases. BioMed Res Int 2015:676575","journal-title":"BioMed Res Int"},{"issue":"4","key":"5880_CR43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3343\/alm.2024.0611","volume":"45","author":"M Yang","year":"2025","unstructured":"Yang M, Zhang A, Chen M, Cao J (2025) Advances in circulating biomarkers for neurodegenerative diseases traumatic brain injuries, and central nervous system tumors. Annals Laboratory Med 45(4):381\u2013390","journal-title":"Annals Laboratory Med"},{"key":"5880_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252010900","author":"RS Alshehri","year":"2024","unstructured":"Alshehri RS, Abuzinadah AR, Alrawaili MS, Alotaibi MK, Alsufyani HA, Alshanketi RM, AlShareef AA (2024) A review of biomarkers of amyotrophic lateral sclerosis: a pathophysiologic approach. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252010900","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5880_CR45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/WCO.0000000000000744","volume":"32","author":"F Verde","year":"2019","unstructured":"Verde F, Silani V, Otto M (2019) Neurochemical biomarkers in amyotrophic lateral sclerosis. Curr Opin Neurol 32(5):747\u2013757","journal-title":"Curr Opin Neurol"},{"key":"5880_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neures.2023.09.002","volume":"197","author":"L Donini","year":"2023","unstructured":"Donini L, Tanel R, Zuccarino R, Basso M (2023) Protein biomarkers for the diagnosis and prognosis of amyotrophic lateral sclerosis. Neurosci Res 197:31\u201341","journal-title":"Neurosci Res"},{"issue":"5","key":"5880_CR47","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","volume":"74","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, et al. (2017) Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease. JAMA Neurol 74(5):525\u2013532","journal-title":"JAMA Neurol"},{"issue":"1","key":"5880_CR48","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, et al. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64(1):60\u201370","journal-title":"Ann Neurol"},{"issue":"5796","key":"5880_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, NY) 314(5796):130\u2013133","journal-title":"Science (New York, NY)"},{"issue":"1","key":"5880_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","volume":"15","author":"E Zucchi","year":"2020","unstructured":"Zucchi E, Bonetto V, Sorar\u00f9 G, Martinelli I, Parchi P, Liguori R, Mandrioli J (2020) Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener 15(1):58","journal-title":"Mol Neurodegener"},{"key":"5880_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cells7110219","author":"C Ricci","year":"2018","unstructured":"Ricci C, Marzocchi C, Battistini S (2018) MicroRNAs as biomarkers in amyotrophic lateral sclerosis. Cells. https:\/\/doi.org\/10.3390\/cells7110219","journal-title":"Cells"},{"key":"5880_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fnmol.2018.00288","volume":"11","author":"M Liguori","year":"2018","unstructured":"Liguori M, Nuzziello N, Introna A, Consiglio A, Licciulli F, D\u2019Errico E, Scarafino A, Distaso E, et al. (2018) Dysregulation of MicroRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288","journal-title":"Front Mol Neurosci"},{"key":"5880_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.12.020","volume":"64","author":"JM Matamala","year":"2018","unstructured":"Matamala JM, Arias-Carrasco R, Sanchez C, Uhrig M, Bargsted L, Matus S, Maracaja-Coutinho V, Abarzua S, et al. (2018) Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol Aging 64:123\u2013138","journal-title":"Neurobiol Aging"},{"issue":"1","key":"5880_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13041-015-0161-7","volume":"8","author":"I Takahashi","year":"2015","unstructured":"Takahashi I, Hama Y, Matsushima M, Hirotani M, Kano T, Hohzen H, Yabe I, Utsumi J, et al. (2015) Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Mol Brain 8(1):67","journal-title":"Mol Brain"},{"key":"5880_CR55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","volume":"368","author":"HM de Andra","year":"2016","unstructured":"de Andra HM, de Albuquerque M, Avansini SH, Rocha CdS, Dogini DB, Nucci A, Carvalho B, Lopes-Cendes I, et al. (2016) MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J Neurol Sci 368:19\u201324","journal-title":"J Neurol Sci"},{"issue":"9","key":"5880_CR56","doi-asserted-by":"publisher","first-page":"2660. e15","DOI":"10.1016\/j.neurobiolaging.2015.06.003","volume":"36","author":"A Freischmidt","year":"2015","unstructured":"Freischmidt A, M\u00fcller K, Zondler L, Weydt P, Mayer B, von Arnim CA, H\u00fcbers A, Dorst J, et al. (2015) Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 36(9):2660. e15-2660. e20","journal-title":"Neurobiol Aging"},{"issue":"4","key":"5880_CR57","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","volume":"18","author":"M Benigni","year":"2016","unstructured":"Benigni M, Ricci C, Jones AR, Giannini F, Al-Chalabi A, Battistini S (2016) Identification of miRNAs as potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients. NeuroMol Med 18(4):551\u2013560","journal-title":"NeuroMol Med"},{"key":"5880_CR58","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jns.2017.07.008","volume":"380","author":"V Pegoraro","year":"2017","unstructured":"Pegoraro V, Merico A, Angelini C (2017) Micro-RNAs in ALS muscle: Differences in gender, age at onset and disease duration. J Neurol Sci 380:58\u201363","journal-title":"J Neurol Sci"},{"issue":"1","key":"5880_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/brainsci9010008","volume":"9","author":"V Pegoraro","year":"2019","unstructured":"Pegoraro V, Merico A, Angelini C (2019) MyomiRNAs dysregulation in ALS rehabilitation. Brain Sci 9(1):8","journal-title":"Brain Sci"},{"key":"5880_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2018.02.009","volume":"114","author":"Y Si","year":"2018","unstructured":"Si Y, Cui X, Crossman DK, Hao J, Kazamel M, Kwon Y, King PH (2018) Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Neurobiol Dis 114:85\u201394","journal-title":"Neurobiol Dis"},{"issue":"4","key":"5880_CR61","first-page":"243","volume":"15","author":"B De Felice","year":"2014","unstructured":"De Felice B, Annunziata A, Fiorentino G, Borra M, Biffali E, Coppola C, Cotrufo R, Brettschneider J, et al. (2014) miR-338-3p is over-expressed in blood. CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients, neurogenetics 15(4):243\u2013253","journal-title":"CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients, neurogenetics"},{"issue":"1","key":"5880_CR62","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.4081\/ejtm.2018.7278","volume":"28","author":"A Merico","year":"2018","unstructured":"Merico A, Cavinato M, Gregorio C, Lacatena A, Gioia E, Piccione F, Angelini C (2018) Effects of combined endurance and resistance training in Amyotrophic Lateral Sclerosis: A pilot, randomized, controlled study. European J Translational Myology 28(1):7278","journal-title":"European J Translational Myology"},{"issue":"3","key":"5880_CR63","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4274\/balkanmedj.galenos.2025.2025-3-60","volume":"42","author":"AS Doghish","year":"2025","unstructured":"Doghish AS, Mansour RM, Mageed SSA, Moustafa HAM, Mohammed OA, Elesawy AE, Rizk NI (2025) Role and Significance of MicroRNAs in the Relationship Between Obesity and Cancer. Balkan Med J 42(3):188","journal-title":"Balkan Med J"},{"issue":"1","key":"5880_CR64","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11883-025-01309-8","volume":"27","author":"RM Mansour","year":"2025","unstructured":"Mansour RM, Hemdan M, Moustafa HAM, Mageed SSA, Rizk NI, Ali MA, Ashour MM, Ashraf A, et al. (2025) Global Perspectives on Coronary Artery Disease: The Emerging Role of miRNAs. Curr Atheroscler Rep 27(1):66","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"5880_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10142-025-01599-w","volume":"25","author":"YM Moustafa","year":"2025","unstructured":"Moustafa YM, Mageed SSA, El-Dakroury WA, Moustafa HAM, Sallam A-AM, Abulsoud AI, Abdelmaksoud NM, Mohammed OA, et al. (2025) Exploring the molecular pathways of miRNAs in testicular cancer: from diagnosis to therapeutic innovations. Funct Integr Genomics 25(1):88","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"5880_CR66","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/jcmm.13976","volume":"23","author":"D Gagliardi","year":"2019","unstructured":"Gagliardi D, Comi GP, Bresolin N, Corti S (2019) Micro RNA s as regulators of cell death mechanisms in amyotrophic lateral sclerosis. J Cell Mol Med 23(3):1647\u20131656","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5880_CR67","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/cells11030572","volume":"11","author":"J Liu","year":"2022","unstructured":"Liu J, Zhou F, Guan Y, Meng F, Zhao Z, Su Q, Bao W, Wang X, et al. (2022) The biogenesis of miRNAs and their role in the development of amyotrophic lateral sclerosis. Cells 11(3):572","journal-title":"Cells"},{"issue":"2","key":"5880_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114234","volume":"442","author":"HAM Moustafa","year":"2024","unstructured":"Moustafa HAM, Elsakka EG, Abulsoud AI, Elshaer SS, Rashad AA, El-Dakroury WA, Sallam A-AM, Rizk NI, et al. (2024) The miRNA Landscape in Crohn\u2019s disease: Implications for novel therapeutic approaches and interactions with Existing therapies. Exp Cell Res 442(2):114234","journal-title":"Exp Cell Res"},{"key":"5880_CR69","doi-asserted-by":"publisher","first-page":"118449","DOI":"10.1016\/j.ijpharm.2019.118449","volume":"567","author":"L Gan","year":"2019","unstructured":"Gan L, Li Z, Lv Q, Huang W (2019) Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model. Int J Pharm 567:118449","journal-title":"Int J Pharm"},{"key":"5880_CR70","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3389\/fphar.2019.01555","volume":"10","author":"D Han","year":"2020","unstructured":"Han D, Dong X, Zheng D, Nao J (2020) MiR-124 and the underlying therapeutic promise of neurodegenerative disorders. Front Pharmacol 10:1555","journal-title":"Front Pharmacol"},{"issue":"11","key":"5880_CR71","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.3390\/ijms22116128","volume":"22","author":"AR Vaz","year":"2021","unstructured":"Vaz AR, Vizinha D, Morais H, Cola\u00e7o AR, Loch-Neckel G, Barbosa M, Brites D (2021) Overexpression of miR-124 in motor neurons plays a key role in ALS pathological processes. Int J Mol Sci 22(11):6128","journal-title":"Int J Mol Sci"},{"key":"5880_CR72","doi-asserted-by":"publisher","first-page":"634355","DOI":"10.3389\/fcell.2021.634355","volume":"9","author":"M Barbosa","year":"2021","unstructured":"Barbosa M, Gomes C, Sequeira C, Gon\u00e7alves-Ribeiro J, Pina CC, Carvalho LA, Moreira R, Vaz SH, et al. (2021) Recovery of depleted miR-146a in ALS cortical astrocytes reverts cell aberrancies and prevents paracrine pathogenicity on microglia and motor neurons. Frontiers in Cell and Developmental Biology 9:634355","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"5880_CR73","doi-asserted-by":"publisher","first-page":"154386","DOI":"10.1016\/j.prp.2023.154386","volume":"244","author":"AS Doghish","year":"2023","unstructured":"Doghish AS, Ali MA, Elyan SS, Elrebehy MA, Mohamed HH, Mansour RM, Elgohary A, Ghanem A, et al. (2023) miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. Pathology-Research and Practice 244:154386","journal-title":"Pathology-Research and Practice"},{"issue":"6415","key":"5880_CR74","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, et al. (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59\u201362","journal-title":"Nature"},{"key":"5880_CR75","doi-asserted-by":"publisher","first-page":"101803","DOI":"10.1016\/j.pneurobio.2020.101803","volume":"190","author":"A Loffreda","year":"2020","unstructured":"Loffreda A, Nizzardo M, Arosio A, Ruepp M-D, Calogero RA, Volinia S, Galasso M, Bendotti C, et al. (2020) miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis. Prog Neurobiol 190:101803","journal-title":"Prog Neurobiol"},{"issue":"1","key":"5880_CR76","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.mcn.2005.10.006","volume":"31","author":"O Butovsky","year":"2006","unstructured":"Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, Martino G, Schwartz M (2006) Microglia activated by IL-4 or IFN-\u03b3 differentially induce neurogenesis and oligodendrogenesis from adult stem\/progenitor cells. Mol Cell Neurosci 31(1):149\u2013160","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"5880_CR77","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.200908164","volume":"187","author":"H Ilieva","year":"2009","unstructured":"Ilieva H, Polymenidou M, Cleveland DW (2009) Non\u2013cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187(6):761","journal-title":"J Cell Biol"},{"issue":"1","key":"5880_CR78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.2015.122","volume":"27","author":"F Borel","year":"2016","unstructured":"Borel F, Gernoux G, Cardozo B, Metterville JP, Cabrera GT, Song L, Su Q, Gao GP, et al. (2016) Therapeutic rAAVrh10 mediated SOD1 silencing in adult SOD1 G93A mice and nonhuman primates. Hum Gene Ther 27(1):19\u201331","journal-title":"Hum Gene Ther"},{"issue":"9","key":"5880_CR79","first-page":"2561","volume":"141","author":"ML Hoye","year":"2018","unstructured":"Hoye ML, Regan MR, Jensen LA, Lake AM, Reddy LV, Vidensky S, Richard J-P, Maragakis NJ, et al. (2018) Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis. Brain 141(9):2561\u20132575","journal-title":"Brain"},{"key":"5880_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116899","volume":"177","author":"Z Alkhazaali-Ali","year":"2024","unstructured":"Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, Tavakol-Afshari J (2024) MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease. Biomed Pharmacother 177:116899","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"5880_CR81","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12031-014-0290-y","volume":"53","author":"K Nolan","year":"2014","unstructured":"Nolan K, Mitchem MR, Jimenez-Mateos EM, Henshall DC, Concannon CG, Prehn JH (2014) Increased expression of microRNA-29a in ALS mice: functional analysis of its inhibition. J Mol Neurosci 53(2):231\u2013241","journal-title":"J Mol Neurosci"},{"issue":"1","key":"5880_CR82","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41598-022-05067-4","volume":"12","author":"N Daneshafrooz","year":"2022","unstructured":"Daneshafrooz N, Joghataei MT, Mehdizadeh M, Alavi A, Barati M, Panahi B, Teimourian S, Zamani B (2022) Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. Sci Rep 12(1):1373","journal-title":"Sci Rep"},{"key":"5880_CR83","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s173632","author":"Q Liu","year":"2018","unstructured":"Liu Q, Hu Y, Zhang M, Yan Y, Yu H, Ge L (2018) MicroRNA-451 protects neurons against ischemia\/reperfusion injury-induced cell death by targeting CELF2. Neuropsychiatr Dis Treat. https:\/\/doi.org\/10.2147\/ndt.s173632","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"5880_CR84","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MOH.0000000000000441","volume":"25","author":"V Menon","year":"2018","unstructured":"Menon V, Ghaffari S (2018) Transcription factors FOXO in the regulation of homeostatic hematopoiesis. Curr Opin Hematol 25(4):290\u2013298","journal-title":"Curr Opin Hematol"},{"key":"5880_CR85","doi-asserted-by":"publisher","first-page":"117906951986279","DOI":"10.1177\/1179069519862798","volume":"13","author":"ME Watts","year":"2019","unstructured":"Watts ME, Wu C, Rubin LL (2019) Suppression of MAP4K4 signaling ameliorates motor neuron degeneration in amyotrophic lateral sclerosis-molecular studies toward new therapeutics. Journal of experimental neuroscience 13:1179069519862798","journal-title":"Journal of experimental neuroscience"},{"issue":"1","key":"5880_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13041-019-0475-y","volume":"12","author":"J Mitra","year":"2019","unstructured":"Mitra J, Hegde PM, Hegde ML (2019) Loss of endosomal recycling factor RAB11 coupled with complex regulation of MAPK\/ERK\/AKT signaling in postmortem spinal cord specimens of sporadic amyotrophic lateral sclerosis patients. Mol Brain 12(1):55","journal-title":"Mol Brain"},{"issue":"5","key":"5880_CR87","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrn1100","volume":"4","author":"M Vila","year":"2003","unstructured":"Vila M, Przedborski S (2003) Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 4(5):365\u2013375","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"5880_CR88","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom A, Burgering BM (2013) FOXOs: signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol 14(2):83\u201397","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5880_CR89","doi-asserted-by":"crossref","unstructured":"W.Y. Ho, L.-L. Chak, J.-H. Hor, F. Liu, S. Diaz-Garcia, J.-C. Chang, E. Sanford, M.J. Rodriguez, D. Alagappan, S.M. Lim, (2023) FUS-dependent microRNA deregulations identify TRIB2 as a druggable target for ALS motor neurons, Iscience 26(11)","DOI":"10.1016\/j.isci.2023.108152"},{"issue":"4","key":"5880_CR90","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/ana.24618","volume":"79","author":"L Stoica","year":"2016","unstructured":"Stoica L, Todeasa SH, Cabrera GT, Salameh JS, ElMallah MK, Mueller C, Brown RH Jr, Sena-Esteves M (2016) Adeno-associated virus\u2013delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model. Ann Neurol 79(4):687\u2013700","journal-title":"Ann Neurol"},{"issue":"1","key":"5880_CR91","first-page":"6782653","volume":"2019","author":"X Sun","year":"2019","unstructured":"Sun X, Guo Q, Wei W, Robertson S, Yuan Y, Luo X (2019) Current progress on microrna-based gene delivery in the treatment of osteoporosis and osteoporotic fracture. Int J Endocrinology 2019(1):6782653","journal-title":"Int J Endocrinology"},{"issue":"1","key":"5880_CR92","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ma15010126","volume":"15","author":"B Niccolini","year":"2021","unstructured":"Niccolini B, Palmieri V, De Spirito M, Papi M (2021) Opportunities offered by graphene nanoparticles for microRNAs delivery for amyotrophic lateral sclerosis treatment. Materials 15(1):126","journal-title":"Materials"},{"issue":"465","key":"5880_CR93","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6414","volume":"10","author":"F Borel","year":"2018","unstructured":"Borel F, Gernoux G, Sun H, Stock R, Blackwood M, Brown RH Jr, Mueller C (2018) Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci Transl Med 10(465):eaau6414","journal-title":"Sci Transl Med"},{"key":"5880_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.102057","author":"SK Chen","year":"2023","unstructured":"Chen SK, Hawley ZC, Zavodszky MI, Hana S, Ferretti D, Grubor B, Hawes M, Xu S, et al. (2023) Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection. Molecular Therapy Nucleic Acids. https:\/\/doi.org\/10.1016\/j.omtn.2023.102057","journal-title":"Molecular Therapy Nucleic Acids"},{"issue":"8","key":"5880_CR95","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1039\/C8TB02946F","volume":"7","author":"Z Bai","year":"2019","unstructured":"Bai Z, Wei J, Yu C, Han X, Qin X, Zhang C, Liao W, Li L, et al. (2019) Non-viral nanocarriers for intracellular delivery of microRNA therapeutics. J Mater Chem B 7(8):1209\u20131225","journal-title":"J Mater Chem B"},{"key":"5880_CR96","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jconrel.2024.11.074","volume":"378","author":"GR Ediriweera","year":"2025","unstructured":"Ediriweera GR, Sivaram AJ, Cowin G, Brown ML, Mcalary L, Lum JS, Fletcher NL, Robinson L, et al. (2025) Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy. J Control Release 378:221\u2013235","journal-title":"J Control Release"},{"issue":"24","key":"5880_CR97","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.3390\/cells11244003","volume":"11","author":"MB Violatto","year":"2022","unstructured":"Violatto MB, Pasetto L, Casarin E, Tondello C, Schiavon E, Talamini L, Marchini G, Cagnotto A, et al. (2022) Development of a Nanoparticle-Based Approach for the Blood-Brain Barrier Passage in a Murine Model of Amyotrophic Lateral Sclerosis. Cells 11(24):4003","journal-title":"Cells"},{"issue":"10","key":"5880_CR98","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41580-020-0251-y","volume":"21","author":"K O\u2019Brien","year":"2020","unstructured":"O\u2019Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO (2020) RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol 21(10):585\u2013606","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5880_CR99","doi-asserted-by":"publisher","first-page":"754630","DOI":"10.3389\/fcell.2021.754630","volume":"9","author":"K Wang","year":"2021","unstructured":"Wang K, Li Y, Ren C, Wang Y, He W, Jiang Y (2021) Extracellular vesicles as innovative treatment strategy for amyotrophic lateral sclerosis. Front Cell Dev Biol 9:754630","journal-title":"Front Cell Dev Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05880-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05880-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05880-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:03:35Z","timestamp":1777907015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05880-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5880"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05880-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"605"}}